Physician profile

Michael Gomez

Urology · Chicago, IL

NPI 1922277268

$59,930.91

in general payments reported to CMS, 2019-2025

62 companies · $19K in 2025

The $19K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Long Term Medical Supply Or Device Loan$34,750.00
Food and Beverage$9,875.74
Travel and Lodging$899.28
Education$103.06

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Angiodynamics, INC. $38,464.32 2022-2025 Nanoknife, Nanoknife
Teleflex LLC $2,480.76 2021-2025 Urolift, Barrigel
Astellas Pharma US INC $1,744.24 2019-2025 Xtandi, Myrbetriq, Veozah
Coloplast Corp $1,551.84 2019-2025 Titan
Sumitomo Pharma America, INC. $1,217.01 2023-2025 Orgovyx, Gemtesa
Janssen Biotech, INC. $1,042.38 2019-2025 Erleada
Olympus America INC. $951.58 2021-2025 Itind System, Cysto-Nephro Videoscope, Olympus
Boston Scientific Corporation $941.98 2019-2025 Ams 700, Rezum Generator
Blue Earth Diagnostics $867.83 2021-2025 Posluma
Merck Sharp & Dohme LLC $801.80 2019-2025 Keytruda, Lynparza
Dendreon Pharmaceuticals LLC $800.92 2019-2025 Provenge
Abbvie INC. $792.84 2019-2025
Bayer Healthcare Pharmaceuticals INC. $777.27 2019-2025
Axonics, INC. $710.84 2021-2024 Axonics, Bulkamid
Ferring Pharmaceuticals INC. $704.91 2019-2025 Adstiladrin
Show all 61 companies
CompanyGeneral paymentsYearsTop products
Travere Therapeutics, INC. $525.89 2019-2021
Astrazeneca Pharmaceuticals LP $443.49 2020-2025 Lynparza, Imfinzi
Endo USA, INC. $391.20 2024-2025 Xiaflex, Aveed
Endo Pharmaceuticals INC. $364.98 2019-2023 Xiaflex, Edex, Aveed
Neotract INC. $364.40 2019-2020
Pfizer INC. $353.90 2019-2025
Antares Pharma, INC. $285.99 2022-2025 Xyosted, Tlando, Nocdurna
Urovant Sciences INC $266.52 2021-2022
Ambu INC. $262.69 2020-2023
Novartis Pharmaceuticals Corporation $253.81 2022-2025
Accord Healthcare, INC. $225.03 2022-2024
Tolmar Pharmaceuticals, INC. $209.32 2019-2022
Amgen INC. $199.03 2019-2023 Xgeva
Tolmar, INC. $197.12 2023-2025 Eligard, Jatenzo
Myovant Sciences INC. $196.84 2021-2022
Allergan, INC. $169.26 2019-2022
Medtronic, INC. $140.71 2022-2025 Interstim
Urogpo LLC $113.09 2019
Cardinal Health 414 LLC $103.71 2022-2023
Comsort, INC $100.00 2019
Clovis Oncology, INC. $70.38 2020
Agiliti Surgical, INC. $65.64 2024-2025 Sonablate Hifu, Koelis Trinity Fusion Biopsy System, Koelis Trinity Mri/US Fusion
Telix Pharmaceuticals $65.45 2023-2025 Illuccix
Urogen Pharma, INC. $62.35 2025
Laborie Medical Technologies Corp. $60.13 2023-2025 Optilume Bph Drug Coated Balloon Catheter
Histosonics, INC. $49.00 2025
Profound Medical Corp. $45.82 2025 Tulsa-Pro
Myriad Genetic Laboratories, INC. $45.31 2024-2025 Prolaris
Procept Biorobotics Corporation $41.82 2024 Aquabeam System
Convatec INC. $40.49 2021-2024
Halozyme INC $36.36 2023
Foundation Medicine, INC. $35.74 2021
180 Medical, INC. $33.28 2023-2025
Tempus Ai, INC $28.59 2024 Xt Cdx
Ethicon US, LLC $24.45 2019
Immunitybio, INC. $24.44 2025
Genzyme Corporation $24.10 2021
Civco Medical Instruments $23.06 2025
Verity Pharmaceuticals INC. $22.77 2022
Progenics Pharmaceuticals, INC. $22.20 2022
Abc Home Medical Supply, INC. $21.08 2022
Avadel Specialty Pharmaceuticals, LLC $19.64 2019
Clarus Therapeutics INC. $16.93 2021
Coopersurgical, INC. $13.21 2020
Dentsply Ih INC. $12.58 2022
Janssen Pharmaceuticals, INC $8.59 2020

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$340,124.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael Gomez

$59,930.91

in general payments reported 2019-2025

Years
2019-2025
Top company
Angiodynamics, INC.
Context
The $19K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/268660/michael-gomez

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.